CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities
Net income	$ 7,327	$ 6,288
Adjustments to reconcile net income to net cash provided by operating activities
Provision for credit losses	670	450
Provision for unfunded commitments	(18)	(31)
Depreciation and amortization	489	373
Loans originated for resale	(218)	(1,606)
Proceeds from sale of loans originated for sale	219	1,255
Net (gains) losses on sale of loans held for sale	(1)	4
Unrealized (gains) losses on equity securities	(69)	222
Net amortization of premium/discount on investment securities	356	582
Net accretion of merger accounting adjustments	(23)	(62)
Net amortization of debt issuance costs	14	14
Amortization of core deposit intangible	84	109
Amortization of right of use asset	103	91
Net change in right of use assets and lease liabilities	(88)	(77)
Increase in cash surrender value of bank owned life insurance	(217)	(213)
(Decrease) increase in deferred income tax benefit	(7)	206
(Increase) decrease in accrued interest receivable	(191)	199
Stock based compensation	198	235
Net change in fair market value above cost of leveraged ESOP shares released	5	6
(Increase) decrease in net deferred loan costs	(851)	283
(Decrease) increase in accrued expenses and other liabilities	(1,545)	586
Decrease in other assets	1,839	1,781
Net Cash Provided by Operating Activities	8,076	10,695
Cash Flows from Investing Activities
Purchase of AFS investment securities	(26)	(46,404)
Proceeds from redemption or principal payments of AFS investment securities	6,388	13,107
Net decrease (increase) of FHLB stock	2,403	(214)
Net change in loans	(22,083)	(39,828)
Purchase of premises and equipment	(168)	(250)
Net Cash Used in Investing Activities	(13,486)	(73,589)
Cash Flows from Financing Activities
Net increase in deposits	65,860	38,919
Payments of long-term debt	0	(18)
Net decrease in short term borrowings	(57,500)	0
Dividends paid	(931)	(949)
Repurchase of common stock	0	(1,550)
Net Cash Provided by Financing Activities	7,429	36,402
Increase (Decrease) in Cash and Cash Equivalents	2,019	(26,492)
Cash and Cash Equivalents - January 1	25,473	139,654
Cash and Cash Equivalents - March 31	27,492	113,162
Cash paid during the period for
Interest	7,632	637
Income taxes	0	0
Supplemental Schedule of Non-Cash Operating Activities
Issuance of common stock for payment of compensation	616	130
Supplemental Schedule of Non-Cash Investing and Financing Activities
Cumulative effect adjustment for adoption of ASU 2016-13	$ 0	$ 2,006